Catatonia in an Alzheimer's dementia patient

Psychogeriatrics

Volumn 8, Issue 1, 2008, Pages 42-44

  Kendurkar, Arvind ^a,b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b Department of Psychiatry ^*  (India)

Author keywords

Alzheimer's dementia; Catatonia; Lorazepam; Quetiapine

Indexed keywords

LORAZEPAM; ORAL ANTIDIABETIC AGENT; QUETIAPINE; RIVASTIGMINE;

ACUTE PSYCHOSIS; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR CHANGE; CASE REPORT; CATATONIA; CLINICAL EVALUATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT PLANNING;

EID: 40349100690     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/j.1479-8301.2007.00218.x     Document Type: Article

References (12)

1. World Health Organization. Tenth Revision of the International Classification of Diseases. Geneva: WHO, 1991.
2. Fink M, Taylor MA. Catatonia: A Clinician's Guide to Diagnosis and Treatment. New York: Cambridge University Press, 2003; 147-169.
3. Takata T, Takaoka K, Fujigaki M. Catatonia in the elderly: A review. Int J Psychiatry Clin Pract 2005; 9: 230-237.
4. Lakshmana R, Sundram S, Cairns F. Dementia with Lewy bodies (DLB) presenting with catatonic symptoms. Psychogeriatrics 2006; 6: 31-34.
5. Heinze M, Andreae D, Grohmann R. Rivastigmin and impaired motor function. Pharmacopsychiatry 2002; 35: 79-80.
6. Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF. Catatonic syndrome in a general psychiatric inpatient population: Frequency, clinical presentation and response to lorazepam. J Clin Psychiatry 1990; 51: 357-362.
7. Cook EH, Olson K, Pliskin N. Response of organic catatonia to risperidone. Arch Gen Psychiatry 1996; 53: 82-83.
8. Hesslinger B, Walden J, Normann C. Acute and long-term treatment of catatonia with risperidone. Pharmacopsychiatry 2001; 34: 25-26.
9. Byerly MJ, Weber MT, Brooks DL. Antipsychotic medications and the elderly: Effects on cognition and implications for use. Drugs Aging 2001; 18: 45-61.
10. Centrrino F, Price BH, Tuttle M. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry 2002; 159: 109-115.
11. Koller EA, Weber J, Doraiswamy PM, Schneider BS. A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus. J Clin Psychiatry 2004; 65: 857-863.
12. Lambert BL, Cunningham FE, Miller DR et al. Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia. Am J Epidemiol 2006; 164: 672-681.